Loading...

150 posters, 16 sessions, 294 authors, 70 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

Obstetric Anaesthesia Annual Scientific Meeting 2024

Thursday 9 - Friday 10 May 2024, Birmingham

Obstetric Anaesthesia Annual Scientific Meeting 2024 banner

6299168

Two case reports of spinal anaesthesia in parturients with high body mass index using height - adjusted doses of 0.5% hyperbaric bupivacaine.

Poster Presenter

Helen Brar

Authors

Christopher McKee, Helen Brar

Affiliations

null,

Part of Topic

Two case reports of spinal anaesthesia in parturients with high body mass index using height – based doses of 0.5% hyperbaric bupivacaine.

Authors

Dr C McKee  Core Anaesthetic Trainee (Year3) University Hospital of North Durham 

Dr H Brar Consultant Anaesthetist University Hospital of North Durham  

Introduction

There is good evidence that single-shot spinal (SSS) doses do not need to be reduced for high body mass index (BMI) [1]. This is supported by observations from our routine practice when using a height-adjusted dosing regimen. However, the possibility that the spread of spinal anaesthesia may be enhanced in those with a BMI of more than 50 kg/m2 has not been ruled out [2]. It is the routine practice of one of the authors (Brar) to use her standard height-based dosing regimen (table 1: doses have since been revised slightly and are shown in brackets). Two case reports are presented, describing successful SSS for elective Caesarean section (CS), in primiparous singleton parturients with term BMIs of greater than 50kg/m2. 

 

Case Report One

A 29-year-old parturient of 160cm height, presented with a weight of 162 kg at 7 weeks gestation (BMI 63kg/m2), rising to 188kg at 28 weeks gestation (BMI 73kg/m2). In the sitting position, a SSS of 2.5ml 0.5% hyperbaric bupivacaine with opioid was injected. The first sensation to cold at ten minutes was up to and including the fourth thoracic dermatome, using ethyl chloride spray. The time from SSS injection to the end of surgery was 102 minutes. 


Case Report Two

A 25-year-old parturient of 179cm height, presented with a weight of 153kg at 8 weeks gestation (BMI 48kg/m2), rising to 180kg at 36 weeks gestation (BMI 56kg/m2). In the sitting position, a SSS of 3.2ml 0.5% hyperbaric bupivacaine was injected, with opioid. The first sensation to cold at ten minutes was up to and including the third thoracic dermatome, using ethyl chloride spray. The time from the SSS injection to the end of surgery was 77 minutes. 


Discussion

Research to establish the ideal intrathecal dose in parturients with BMI above 50kg/m2, is limited. Combined spinal epidural (CSE) may have advantages over SSS, by allowing lower intrathecal doses to be used, with the ability to raise the sensory level if needed. The Tuohy needle can act as a guide for the spinal needle, and the epidural catheter can be used to maintain anaesthesia during prolonged surgery. SSS reduces time in the sitting position, which may itself lower the spinal block. There are no risks of using an untested catheter, catheter failure, or high spinal block after catheter top-up. We do not reduce the intrathecal dose in such parturients when using a height–adjusted regimen. We have found no signs of high spinal block, even when using relatively large doses in taller parturients.


References

1. Ngaka TC, Coetzee JF, Dyer RA. The influence of Body Mass Index on Sensorimotor Block and Vasopressor Requirement During Spinal Anesthesia for Elective Cesarean Delivery. Anesthesia and Analgesia. 2016; 123:1527-34.

2. Lamon AM, Einhorn LM, Cooter M, Habib AS. The impact of body mass index on the risk of high spinal block in parturients undergoing cesarean delivery: a retrospective cohort study. Journal of Anesthesia. 2017; 31: 552–8

Obstetric Anaesthesia Annual Scientific Meeting 2024 » banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.